Operator: Good morning, and welcome to Mersana Therapeutics Fourth Quarter and Year End 2022 Conference Call and Webcast. Currently, all participants are in a listen-only mode.
Merck KGaA and Mersana partner in potential $830m deal pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
Collaboration focuses on discovering novel STING-agonist ADCs for up to two targets leveraging Mersana's proprietary immunostimulatory platform Mersana to receive $30 million upfront payment, up to $800
Merck Announces Collaboration with Mersana Therapeutics to Develop Novel Immunostimulatory Antibody-Drug Conjugates q8dailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from q8dailynews.com Daily Mail and Mail on Sunday newspapers.
Mersana Therapeutics (MRSN) Announces Research Collaboration and Commercial License Agreement with Merck KGaA, Darmstadt, Germany streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.